MERCER GLOBAL ADVISORS INC /ADV
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 853758
DENVER, CO
Position in IRWD
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$531,133
+$127,203 QoQ
Shares Held
126,160
+9.6% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 212 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,567,425 across 30 Drug Manufacturers - Specialty & Generic names. IRWD ranks #15 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
56,839 | $9,579,645 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
16,741 | $9,070,776 | |
| 3 | ZTS |
Zoetis Inc.
|
66,412 | $4,772,366 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,856 | $2,690,731 | |
| 5 | VTRS |
Viatris Inc
|
160,652 | $2,551,153 | |
| 6 | HLN |
Haleon plc
|
259,261 | $2,418,905 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,403 | $2,385,253 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
74,362 | $1,830,048 |
All Filings in IRWD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $531,133 | 126,160 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $403,930 | 115,080 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $259,324 | 76,951 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $93,472 | 71,353 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,058 | 33,415 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $63,101 | 15,316 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $108,251 | 16,603 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,057,502 | 236,223 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,750,564 | 240,434 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,356,932 | 244,749 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,234,527 | 210,012 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,992,509 | 189,402 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,218,256 | 179,036 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,835,066 | 177,130 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,023,180 | 175,471 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,963,096 | 156,049 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,453,034 | 124,617 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $803,412 | 61,517 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $623,397 | 48,438 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $513,027 | 45,888 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $540,364 | 47,442 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $332,998 | 37,041 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $366,948 | 35,557 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||